Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. [electronic resource]
Producer: 20200103Description: 407-413 p. digitalISSN:- 1549-4713
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Diabetes Mellitus, Type 1 -- complications
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Retinopathy -- drug therapy
- Female
- Humans
- Intravitreal Injections
- Laser Coagulation
- Lost to Follow-Up
- Male
- Middle Aged
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retinal Neovascularization -- drug therapy
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.